Global Spine was Orthofix Medical’s largest segment in fiscal 2025, bringing in $645.14M of $779.80M (83%).
| Segment | FY 2009 | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Global Spine | $353.17M | $631.32M | $675.31M | $645.14M | |||||||||||||
| Domestic | — | — | — | — | |||||||||||||
| Revenue, Net | — | — | — | — | |||||||||||||
| Biostim | — | — | — | — | |||||||||||||
| Bone Growth Therapies | — | — | — | — | |||||||||||||
| Global Limb Reconstruction | — | $115.32M | $124.18M | $134.66M | |||||||||||||
| Extremity Fixation | — | — | — | — | |||||||||||||
| Spine Fixation | — | — | — | — | |||||||||||||
| Spinal Implants | — | — | — | — | |||||||||||||
| Orthofix Extremities | — | — | — | — | |||||||||||||
| Biologics | — | — | — | — | |||||||||||||
| International | — | — | — | — | |||||||||||||
| Global Orthopedics | $26.00M | — | — | — | |||||||||||||
| Global Extremities | — | — | — | — | |||||||||||||
| Total | $379.17M | $746.64M | $799.49M | $779.80M |
Orthofix Medical brought in $779.80M from its two segments in fiscal 2025, the year ended December 31, 2025. That was down 2.5% from $799.49M in fiscal 2024. Global Spine was the largest at $645.14M (82.7%), ahead of Global Limb Reconstruction at $134.66M (17.3%).
Compared with fiscal 2024, Global Limb Reconstruction grew 8.4% to $134.66M, while Global Spine fell 4.5% to $645.14M.
Orthofix Medical began breaking out Global Limb Reconstruction in fiscal 2023, when it brought in $115.32M. Orthofix Medical stopped reporting Global Orthopedics as a separate segment after fiscal 2022, when it brought in $26.00M.
U.S was Orthofix Medical’s largest region in fiscal 2025, bringing in $645.14M of $749.17M (86%).
| Geography | FY 2010 | FY 2011 | FY 2012 | FY 2013 | FY 2014 | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| U.S | $332.85M | $591.94M | $639.20M | $645.14M | ||||||||||||
| Others | — | $65.83M | $66.40M | — | ||||||||||||
| International | $20.33M | — | $36.12M | $42.52M | ||||||||||||
| Italy | $19.10M | $20.06M | $21.00M | $22.28M | ||||||||||||
| Brazil | $5.67M | $6.45M | $5.71M | $4.84M | ||||||||||||
| United Kingdom | $10.17M | $10.91M | $11.18M | $13.33M | ||||||||||||
| U.K | — | — | — | — | ||||||||||||
| France | $10.38M | $11.10M | $13.39M | $11.96M | ||||||||||||
| Germany | $11.57M | $11.47M | $9.00M | $9.11M | ||||||||||||
| Total | $410.06M | $717.75M | $801.99M | $749.17M |
Orthofix Medical brought in $749.17M from its seven regions in fiscal 2025, the year ended December 31, 2025. Orthofix Medical regrouped these regions after fiscal 2024, so the total does not compare directly with that year's $801.99M. U.S was the largest at $645.14M (86.1%), ahead of International at $42.52M (5.7%) and Italy at $22.28M (3.0%). The other four regions brought in $39.24M combined.
Compared with fiscal 2024, International grew fastest, up 17.7% to $42.52M. Every region above 2% of revenue grew. From fiscal 2022 to 2025, combined revenue from these regions grew from $410.06M to $749.17M, a compound annual growth rate of 22.2%. U.S's share of the total rose from 81.2% to 86.1%.
Orthofix Medical stopped reporting Others as a separate region after fiscal 2024, when it brought in $66.40M.
Distributor Revenue was Orthofix Medical’s largest revenue line in fiscal 2011, bringing in $470.00M of $413.21M (114%).
| Scenario | FY 2011 |
|---|---|
| Distributor Revenue | $470.00M |
| Further Restatement | -$492.00K |
| Original Restatement | -$56.30M |
| Total | $413.21M |
Orthofix Medical brought in $413.21M from its three revenue lines in fiscal 2011, the year ended December 31, 2011. Distributor Revenue was the largest at $470.00M (113.7%).
The total is net of Further Restatement, which took $492.00K off revenue in fiscal 2011.
Orthofix Medical (OFIX) reports its revenue by segment, by geography and by scenario. In fiscal 2025, Global Spine was its largest segment, bringing in $645.14M (82.7% of the total), followed by Global Limb Reconstruction at $134.66M (17.3%).
Global Spine was Orthofix Medical's largest segment in fiscal 2025, bringing in $645.14M, or 82.7% of the $779.80M total across its two segments.
U.S was Orthofix Medical's largest region in fiscal 2025, bringing in $645.14M, or 86.1% of the $749.17M total across its seven regions.
Distributor Revenue was Orthofix Medical's largest revenue line in fiscal 2011, bringing in $470.00M, or 113.7% of the $413.21M total across its three revenue lines.
Global Limb Reconstruction grew faster than Global Spine in fiscal 2025, up 8.4% from $124.18M to $134.66M. Global Spine fell 4.5% to $645.14M.
Every figure comes from Orthofix Medical's annual financial filings, as reported. Each line keeps the name Orthofix Medical gives it, and years follow its fiscal calendar.
Orthofix Medical's revenue by segment goes back to fiscal 2009, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.